Bile Acid Sequestrants and the Treatment of Type 2 Diabetes Mellitus

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.10, 2007-01, pp. : 1383-1392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus: Focus on Bile Acid Sequestrants

By >

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M. Jarvis B.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

By Landgraf R.

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 411-425

Adis International

Access to resources Recommend Favorite

Orlistat in the treatment of Type 2 diabetes mellitus

By Jneidi Muna Kelley David E

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin in the treatment of type 2 diabetes mellitus

By Stamataros George Schneider Stephen H

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1967-1973

Informa Healthcare

Access to resources Recommend Favorite